Dr. Julen Oyarzabal has been appointed director deTraslación deTraslación de Ciencia Básica y manager del committee de seguimiento de proyectos traslacionales del research center Applied Medicine (CIMA) of the University of Navarra. He will combine his position with the management of the Small Molecule Platform finding , a position he has held since 2010.

The Basic Science Translational department has been created to promote the early development of products from the basic research of CIMA, at partnership with the Schools and the Clínica Universidad de Navarra. Dr. Oyarzabal will oversee the translational focus of the center's basic research , as well as the translational integration of the research services, and will be in charge of strengthening links with companies, which will allow the development subsequent of the products.

D. in Organic Chemistry from the University of the Basque Country, Dr. Oyarzabal completed two postdoctoral stays at the Universities of California (San Francisco, USA) and Southampton (England). In 2001 he returned to Spain to work as a senior scientist at the area of the Central Nervous System of the research center Basics of Johnson & Johnson (J&J), in Toledo. Until joining CIMA, he was manager of the Computational Medical Chemistry Section of the Spanish National Cancer Research Center (CNIO) where he simultaneously led drug finding projects. He is co-inventor of more than 15 patents and member of the expert panel of the European Medicines Agency (EMA).